A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway
Article in Journal of Translational Medicine (February 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Journal of Translational Medicine (February 2024)
Article in Frontiers in Immunology (August 2023)
Preprint in Research Square (February 2023)